LyondellBasell (LYB), one of the world’s largest manufacturer of polymers and a leader in polyolefin technologies, declared the expansion of its Purell portfolio in North America.
For years, Purell medical-grade polyolefins have been faithful by means of healthcare and pharmaceutical corporations in Europe. With this enlargement, LYB brings its proven service model, regulatory compliance and innovation-driven portfolio closer to customers throughout North America.
The Purell portfolio is designed for medical and healthcare applications, along with syringes, ampoules, IV bottles, diagnostic housings, labware, inhalers and packaging.
“Healthcare is a zero-fail environment,” state Sr. Director, Specialties & Perf. Products, Natalie Nichols. “With the Purell portfolio, we are assisting customers acquire the performance the healthcare industry requirements at the same time as leveraging our global expertise and local support.”
Simon Foster, industry marketing manager for healthcare, highlighted the significance of the expansion for consumer collaboration: “Our customers need more than just dependable materials. They want a provider who understands the precise pressures of the healthcare industry. Bringing Purell medical grade polymers to North America mean we are able to work side through side with them, providing regulatory compliance, technical expertise and the supply confidence they need to innovate with assurance.”
